Simplex Trading
PCVX icon

Simplex Trading’s Vaxcyte PCVX Stock Holding History

Simplex Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,549
Closed -$84.1K – 9876
2025
Q4 		$71.5K Buy
+1,549
New +$69.3K ﹤0.01% 5319
2025
Q1 		– Sell
-12,818
Closed -$1.02M – 9368
2024
Q4 		$1.05M Buy
12,818
+12,485
+3,749% +$1.24M ﹤0.01% 2792
2024
Q3 		$38K Buy
+333
New +$30K ﹤0.01% 6141
2023
Q1 		– Sell
-9,776
Closed -$415K – 9848
2022
Q4 		$468K Sell
9,776
-197
-2% -$7.73K ﹤0.01% 3219
2022
Q3 		$239K Buy
9,973
+9,667
+3,159% +$245K ﹤0.01% 4388
2022
Q2 		$6K Buy
+306
New +$7.08K ﹤0.01% 8738

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's PCVX Position: Q1 2026 in Review

Simplex Trading sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 1,549 shares — an estimated $84.1K sold.

Simplex Trading first reported a position in PCVX in Q2 2022 and held it in 6 quarters. The position peaked at $1.05M in Q4 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Simplex Trading reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,549 Vaxcyte shares in Q1 2026, an estimated $84.1K.
  • Simplex Trading first reported a position in Vaxcyte in Q2 2022 and held it in 6 quarters.
  • Simplex Trading's Vaxcyte position peaked at $1.05M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.